结核暴露与葡萄膜炎患者白塞病风险
该研究采用孟德尔随机化和观察性分析,在中国队列(999例白塞病相关葡萄膜炎、1585例其他葡萄膜炎、4417例对照)和日本队列(611例白塞病、737例对照)中评估结核感染与白塞病风险的关联。遗传决定的结核易感性与白塞病风险升高相关(OR 1.26, 95%CI 1.12-1.43),T-SPOT.TB阳性也是白塞病的独立危险因素(OR 2.26, 95%CI 1.11-4.60)。
要点
- 遗传决定的结核易感性与白塞病风险升高相关,中国队列OR 1.26,日本队列OR 1.16。
- T-SPOT.TB阳性提示既往结核感染,与白塞病风险独立相关(OR 2.26)。
- 该研究为感染因素与非感染性葡萄膜炎风险关联提供了新证据。
核心结论
- 结核暴露是白塞病的危险因素,将感染因素与非感染性葡萄膜炎风险联系起来。
研究设计与样本
- 研究采用孟德尔随机化和观察性分析,使用中国队列(2008年4月至2018年1月入组)和日本队列(2002年1月至2009年6月入组)的遗传数据。
- 中国队列包括999例白塞病相关葡萄膜炎患者、1585例其他葡萄膜炎患者和4417例对照。
- 日本队列包括611例白塞病患者和737例对照;T-SPOT.TB检测组包括116例白塞病患者和121例对照。
主要发现
- 在中国队列中,遗传决定的结核易感性与白塞病风险升高相关,结核发病率每增加2倍,白塞病OR为1.26(95%CI 1.12-1.43;P=1.47×10-4)。
- 日本队列复制结果相似,OR为1.16(95%CI 1.08-1.26)。
- T-SPOT.TB阳性是白塞病的独立危险因素(OR 2.26,95%CI 1.11-4.60)。
关键数值与推荐
- 在中国队列中,遗传决定的结核易感性与白塞病风险升高相关,结核发病率每增加2倍,OR为1.26(95%CI 1.12-1.43;P=1.47×10-4)。
- 日本队列中OR为1.16(95%CI 1.08-1.26)。
- T-SPOT.TB阳性与白塞病风险独立相关,OR为2.26(95%CI 1.11-4.60)。
临床怎么用
- 对于葡萄膜炎患者,尤其是白塞病相关葡萄膜炎,应考虑评估结核感染史。
- T-SPOT.TB检测可能有助于识别白塞病风险升高的个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although experimental studies support the hypothesis that exposure of infectious agents may trigger an aberrant immune response and contribute to noninfectious uveitis, the association of a definite pathogen with human noninfectious uveitis conditions appears not to have been well established in a population. OBJECTIVE: To evaluate associations of tuberculosis infection with risk of several noninfectious uveitis conditions. DESIGN, SETTING, AND PARTICIPANTS: These mendelian randomization and observational analyses were conducted with the genetic data of a Chinese cohort enrolled between April 2008 and January 2018 and a Japanese cohort enrolled between January 2002 and June 2009. We recruited participants for T-SPOT.TB (Oxford Immunotec) assays between July and November 2019. The Chinese cohort included patients with uveitis associated with Behçet disease or other uveitis conditions and control participants. The Japanese cohort and the group given T-SPOT.TB assays included individuals with Behçet disease and control participants. Data analyses for this study were completed from July 2019 to January 2020. EXPOSURES: Genetic variants associated with tuberculosis as natural proxies for tuberculosis exposure. MAIN OUTCOMES AND MEASURES: The primary outcome was the odds ratio (OR) for Behçet disease, estimated by an inverse variance weighted mean of associations with genetically determined tuberculosis susceptibility. The T-SPOT.TB positivity rate was examined in individuals with Behçet disease and compared with that of control participants. RESULTS: The Chinese cohort included 999 patients with uveitis associated with Behçet disease, 1585 with other uveitis conditions, and 4417 control participants. The Japanese cohort included 611 individuals with Behçet disease and 737 control participants. The group given T-SPOT.TB assays included 116 individuals with Behçet disease and 121 control participants. Of the Chinese individuals with Behçet disease and control participants, 2257 (41.7%) were female and the mean (SD) age was 35.4 (12.5) years. In the Japanese cohort, 564 (41.8%) were female and the mean (SD) age was 39.1 (12.7) years. Genetically determined tuberculosis susceptibility was associated with an increased risk for Behçet disease. The OR for Behçet disease per 2-fold increase in tuberculosis incidence was 1.26 (95% CI, 1.12-1.43; P = 1.47 × 10-4). Replication using the Japanese cohort yielded similar results (OR, 1.16 [95% CI, 1.08-1.26]). In T-SPOT.TB assays, having a positive result, indicating a history of tuberculosis infection, was found to be an independent risk factor for Behçet disease (OR, 2.26 [95% CI, 1.11-4.60]). CONCLUSIONS AND RELEVANCE: These human genetic and biomarker data demonstrated that tuberculosis exposure was a risk factor for Behçet disease. This study provides novel evidence linking an infectious agent to the risk of a noninfectious uveitis condition.
引用
- Zhong Z, Su G, Zhou Q, et al. Tuberculosis Exposure With Risk of Behçet Disease Among Patients With Uveitis. JAMA Ophthalmol. 2021. PMID: 33599689. doi:10.1001/jamaophthalmol.2020.6985
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。